GlassScriptPhysician profile
Kaya Caldwell
NPI 1013029826
$22,088.48
in general payments reported to CMS, 2019-2025
68 companies · $2,697 in 2025
The $2,697 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,495 · 2020: $2,105 · 2021: $5,125 · 2022: $2,760 · 2023: $3,395 · 2024: $3,511 · 2025: $2,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,601 · Education: $2.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,601.24 |
| Education | $2.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,975.92 | 2019-2025 | Qulipta, Vraylar, Ubrelvy |
| Novo Nordisk INC | $2,967.92 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,610.05 | 2020-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $1,472.94 | 2021 | |
| Amgen INC. | $1,290.56 | 2019-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,247.35 | 2019-2025 | Farxiga, Airsupra, Bevespi Aerosphere |
| Lilly USA, LLC | $968.45 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Allergan, INC. | $912.51 | 2019-2020 | |
| Pfizer INC. | $888.72 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $654.39 | 2019-2025 | Trintellix |
| Axsome Therapeutics, INC. | $530.89 | 2023-2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $522.07 | 2019-2025 | Trulance, Xifaxan |
| Amarin Pharma, INC. | $480.19 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $352.59 | 2019-2024 | Livalo, Seglentis |
| Otsuka America Pharmaceutical, INC. | $320.12 | 2020-2024 | Rexulti |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $272.24 | 2019-2025 | Wellbutrin, Aplenzin |
| Astellas Pharma US INC | $271.78 | 2019-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.49 | 2019-2024 | Ofev, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $257.83 | 2022 | |
| Merck Sharp & Dohme LLC | $237.45 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Eisai INC. | $213.50 | 2020-2025 | |
| Exact Sciences Corporation | $205.34 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $152.88 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $123.88 | 2020-2025 | Nexletol |
| Amneal Pharmaceuticals LLC | $119.23 | 2019-2023 | Unithroid |
| Bayer Healthcare Pharmaceuticals INC. | $117.92 | 2023-2025 | |
| Inspire Medical Systems, INC. | $109.97 | 2024-2025 | Inspire |
| Sanofi Pasteur INC. | $90.53 | 2019-2025 | |
| Teleflex LLC | $86.59 | 2025 | Barrigel |
| Sanofi-Aventis U.S. LLC | $83.00 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $81.01 | 2022-2023 | |
| Lundbeck LLC | $64.92 | 2021-2025 | Rexulti |
| Boston Scientific Corporation | $60.72 | 2024 | Wavewriter Alpha Prime 16 |
| Vbi Vaccine (Delaware) INC. | $60.12 | 2023 | Prehevbrio |
| Mannkind Corporation | $59.40 | 2022 | |
| Smith+Nephew, INC. | $57.36 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $55.95 | 2019 | |
| Ironwood Pharmaceuticals, INC | $55.04 | 2020-2022 | |
| Dexcom, INC. | $54.61 | 2023-2025 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $49.89 | 2023-2024 | Quviviq |
| Endo Pharmaceuticals INC. | $49.02 | 2019-2021 | |
| Genentech USA, INC. | $42.79 | 2019-2021 | |
| Horizon Therapeutics Plc | $41.74 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $40.03 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $36.82 | 2020-2022 | |
| Medtronic, INC. | $34.05 | 2024 | Interstim |
| Ibsa Pharma INC. | $30.35 | 2020 | |
| Shield Therapeutics INC | $29.12 | 2024 | |
| Therapeuticsmd, INC. | $27.59 | 2019 | |
| Aytu Biopharma, INC. | $26.59 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $26.19 | 2019 | |
| Echosens North America, INC. | $25.18 | 2024 | Fibroscan |
| Nevro Corp. | $24.95 | 2023 | Senza |
| Vital Connect, INC | $24.78 | 2025 | Vitalpatch Rtm |
| Assertio Therapeutics, INC. | $24.05 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $21.57 | 2023 | Strensiq |
| Philips North America LLC | $19.35 | 2024 | (Ck7) Extended Holter |
| Vivus LLC | $19.32 | 2021 | |
| Sumitomo Pharma America, INC. | $18.15 | 2025 | Gemtesa |
| Seqirus USA INC | $17.83 | 2022 | |
| Impel Pharmaceuticals INC. | $16.08 | 2023 | Trudhesa |
| Mission Pharmacal Company | $15.15 | 2019 | |
| Kaleo, INC. | $14.84 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.67 | 2019 | |
| Linus Health, INC. | $14.66 | 2024 | Core Cognitive Evaluation |
| Gilead Sciences, INC. | $12.71 | 2020 | |
| Upsher-Smith Laboratories LLC | $12.31 | 2020 | |
| Mayne Pharma Commercial LLC | $12.27 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaya Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.